1. Клинические рекомендации «ВИЧ-инфекция у взрослых». Министерство здравоохранения Российской Федерации, 2024. https: //cr.minzdrav.gov.ru/recomend/79_2 (дата обращения: 20.06.2026).
2. Antinori A., Arendt G., Becker J.T. et al. Updated research nosology for HIV-associated neurocognitive disorders // Neurology. – 2007. – Vol. 69. – N 18. – P. 1789–1799. Doi:https://doi.org/10.1212/01.WNL.0000287431.88658.8b
3. Heaton R.K., Clifford D.B., Franklin D.R. Jr. et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study // Neurology. – 2010. – Vol. 75. – N 23. – P. 2087–2096. Doi:https://doi.org/10.1212/WNL.0b013e318200d727
4. Wang Y., Liu M., Lu Q. et al. Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis // Neurology. – 2020. – Vol.
5. Saylor D., Dickens A.M., Sacktor N. et al. HIV-associated neurocognitive disorder: pathogenesis and prospects for treatment // Nature Reviews Neurology. – 2016. – Vol. 12. – N 4. – P. 234–248. Doi:https://doi.org/10.1038/nrneurol.2016.27
6. Williams D.W., Veenstra M., Gaskill P.J., Morgello S., Calderon T.M., Berman J.W. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV-associated neurocognitive disorders // Current HIV Research. – 2014. – Vol. 12. – N 2. – P. 85–96. Doi:https://doi.org/10.2174/1570162X12666140526114526
7. Kamat A., Lyons J.L., Misra V. et al. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection // Journal of Acquired Immune Deficiency Syndromes. – 2012. – Vol. 60. – N 3. – P. 234–243. Doi:https://doi.org/10.1097/QAI.0b013e318256f3bc
8. Mu W., Patankar V., Kitchen S., Zhen A. Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection // Viruses. – 2024. – Vol. 16. – N 2. – Article 219. Doi:https://doi.org/10.3390/v16020219
9. Кныш С.В., Маркелова Е.В., Кузнецов А.С., Горелова И.С. Хронический воспалительный ландшафт при ВИЧ-инфекции: характеристика факторов врожденного иммунитета // Инфекция и иммунитет. – 2025. – Т. 15. – № 4. – С. 681–688. Doi:https://doi.org/10.15789/2220-7619-TCI-17882
10. Ellis R.J., Badiee J., Vaida F. et al. CD4+ nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy // AIDS. – 2011. – Vol. 25. – N 14. – P. 1747–1751. Doi:https://doi.org/10.1097/QAD.0b013e32834a40cd
11. Heaton R.K., Franklin D.R. Jr., Ellis R.J. et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors // Journal of NeuroVirology. – 2011. – Vol. 17. – N 1. – P. 3–16. Doi:https://doi.org/10.1007/s13365-010-0006-1
12. Garabet R., Dampier W., Tillman S. et al. CD4+ nadir and neurocognitive trajectories in people living with HIV // Journal of NeuroVirology. – 2024. – Vol. 30. – N 4. – P. 423–433. Doi:https://doi.org/10.1007/s13365-024- 01217-8
13. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults // MMWR Recommendations and Reports. – 1992. – Vol. 41. – N RR–17. – P. 1–19. https: //www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm
14. Rubin L.H., Neigh G.N., Sundermann E.E., Xu Y., Scully E.P., Maki P.M. Sex differences in neurocognitive function in adults with HIV: patterns, predictors, and mechanisms // Current Psychiatry Reports. – 2019. – Vol. 21. – N 10. – Article 94. Doi:https://doi.org/10.1007/s11920-019-1089-x
15. Sundermann E.E., Heaton R.K., Pasipanodya E. et al. Sex differences in HIV-associated cognitive impairment // AIDS. – 2018. – Vol. 32. – N 18. – P. 2719–2726. Doi:https://doi.org/10.1097/QAD.0000000000002012
16. Wilson M.E., Dimayuga F.O., Reed J.L., Curry T.E., Anderson C.F., Nath A., Bruce-Keller A.J. Immune modulation by estrogens: role in CNS HIV-1 infection // Endocrine. – 2006. – Vol. 29. – N 2. – P. 289–297. Doi:https://doi.org/10.1385/ENDO: 29:2:289
17. Маркелова Е.В., Бениова С.Н., Кныш С.В., Горелова И.С., Огнева З.В., Елисеева В.С., Чагина Е.А. Промежуточные результаты оценки лекарственной устойчивости ВИЧ у пациентов, проживающих на территории Приморского края // Тихоокеанский медицинский журнал. – 2024. – № 4. – С. 63–68. https: //doi.org/10.34215/1609-1175-2024-4-63-68
